Mu-Chun Li

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Mu-Chun Li, You-Liang Lai, Po-Hsien Kuo, Julakanti Satyanarayana Reddy, Chih-Ming Chen, Julakanti Manimala, Pei-Chen Wang, Ming-Shiem Wu, Chun-Yu Chang, Chen-Ming Yang, Chin-Yu Lin, Yu-Chen Huang, Chun-Hsien Chiu, Ling Chang, Wen-Hsing Lin, Teng-Kuang Yeh, Wan-Ching Yen, Hsing-Pang Hsieh
Discovery of Dual MER/AXL Kinase Inhibitors as Bifunctional Small Molecules for Inhibiting Tumor Growth and Enhancing Tumor Immune Microenvironment. Journal of medicinal chemistry 67 (13) (2024)
Mu-Chun Li, You-Liang Lai, Po-Hsien Kuo, Julakanti Satyanarayana Reddy, Chih-Ming Chen, Julakanti Manimala, Pei-Chen Wang, Ming-Shiem Wu, Chun-Yu Chang, Chen-Ming Yang, Chin-Yu Lin, Yu-Chen Huang, Chun-Hsien Chiu, Ling Chang, Wen-Hsing Lin, Teng-Kuang Yeh, Wan-Ching Yen, Hsing-Pang Hsieh
Discovery of Dual MER/AXL Kinase Inhibitors as Bifunctional Small Molecules for Inhibiting Tumor Growth and Enhancing Tumor Immune Microenvironment. Journal of medicinal chemistry 67 (13) (2024)
Mu-Chun Li, You-Liang Lai, Po-Hsien Kuo, Julakanti Satyanarayana Reddy, Chih-Ming Chen, Julakanti Manimala, Pei-Chen Wang, Ming-Shiem Wu, Chun-Yu Chang, Chen-Ming Yang, Chin-Yu Lin, Yu-Chen Huang, Chun-Hsien Chiu, Ling Chang, Wen-Hsing Lin, Teng-Kuang Yeh, Wan-Ching Yen, Hsing-Pang Hsieh
Discovery of Dual MER/AXL Kinase Inhibitors as Bifunctional Small Molecules for Inhibiting Tumor Growth and Enhancing Tumor Immune Microenvironment. Journal of medicinal chemistry (2024)
Mu-Chun Li, You-Liang Lai, Po-Hsien Kuo, Julakanti Satyanarayana Reddy, Chih-Ming Chen, Julakanti Manimala, Pei-Chen Wang, Ming-Shiem Wu, Chun-Yu Chang, Chen-Ming Yang, Chin-Yu Lin, Yu-Chen Huang, Chun-Hsien Chiu, Ling Chang, Wen-Hsing Lin, Teng-Kuang Yeh, Wan-Ching Yen, Hsing-Pang Hsieh
Discovery of Dual MER/AXL Kinase Inhibitors as Bifunctional Small Molecules for Inhibiting Tumor Growth and Enhancing Tumor Immune Microenvironment. Journal of medicinal chemistry 67 (13) (2024)
Mu-Chun Li, You-Liang Lai, Po-Hsien Kuo, Julakanti Satyanarayana Reddy, Chih-Ming Chen, Julakanti Manimala, Pei-Chen Wang, Ming-Shiem Wu, Chun-Yu Chang, Chen-Ming Yang, Chin-Yu Lin, Yu-Chen Huang, Chun-Hsien Chiu, Ling Chang, Wen-Hsing Lin, Teng-Kuang Yeh, Wan-Ching Yen, Hsing-Pang Hsieh
Discovery of Dual MER/AXL Kinase Inhibitors as Bifunctional Small Molecules for Inhibiting Tumor Growth and Enhancing Tumor Immune Microenvironment. Journal of medicinal chemistry 67 (13) (2024)
Mu-Chun Li, Mohane Selvaraj Coumar, Shu-Yu Lin, Yih-Shyan Lin, Guan-Lin Huang, Chun-Hwa Chen, Tzu-Wen Lien, Yi-Wen Wu, Yen-Ting Chen, Ching-Ping Chen, Yu-Chen Huang, Kai-Chia Yeh, Chen-Ming Yang, Bikashita Kalita, Shiow-Lin Pan, Tsu-An Hsu, Teng-Kuang Yeh, Chiung-Tong Chen, Hsing-Pang Hsieh
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer. Journal of medicinal chemistry 66 (4) (2023)
Mu-Chun Li, Mohane Selvaraj Coumar, Shu-Yu Lin, Yih-Shyan Lin, Guan-Lin Huang, Chun-Hwa Chen, Tzu-Wen Lien, Yi-Wen Wu, Yen-Ting Chen, Ching-Ping Chen, Yu-Chen Huang, Kai-Chia Yeh, Chen-Ming Yang, Bikashita Kalita, Shiow-Lin Pan, Tsu-An Hsu, Teng-Kuang Yeh, Chiung-Tong Chen, Hsing-Pang Hsieh
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer. Journal of medicinal chemistry 66 (4) (2023)
Mu-Chun Li, Mohane Selvaraj Coumar, Shu-Yu Lin, Yih-Shyan Lin, Guan-Lin Huang, Chun-Hwa Chen, Tzu-Wen Lien, Yi-Wen Wu, Yen-Ting Chen, Ching-Ping Chen, Yu-Chen Huang, Kai-Chia Yeh, Chen-Ming Yang, Bikashita Kalita, Shiow-Lin Pan, Tsu-An Hsu, Teng-Kuang Yeh, Chiung-Tong Chen, Hsing-Pang Hsieh
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer. Journal of medicinal chemistry 66 (4) (2023)
Mu-Chun Li, Mohane Selvaraj Coumar, Shu-Yu Lin, Yih-Shyan Lin, Guan-Lin Huang, Chun-Hwa Chen, Tzu-Wen Lien, Yi-Wen Wu, Yen-Ting Chen, Ching-Ping Chen, Yu-Chen Huang, Kai-Chia Yeh, Chen-Ming Yang, Bikashita Kalita, Shiow-Lin Pan, Tsu-An Hsu, Teng-Kuang Yeh, Chiung-Tong Chen, Hsing-Pang Hsieh
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer. Journal of medicinal chemistry 66 (4) (2023)
Mu-Chun Li, Mohane Selvaraj Coumar, Shu-Yu Lin, Yih-Shyan Lin, Guan-Lin Huang, Chun-Hwa Chen, Tzu-Wen Lien, Yi-Wen Wu, Yen-Ting Chen, Ching-Ping Chen, Yu-Chen Huang, Kai-Chia Yeh, Chen-Ming Yang, Bikashita Kalita, Shiow-Lin Pan, Tsu-An Hsu, Teng-Kuang Yeh, Chiung-Tong Chen, Hsing-Pang Hsieh
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer. Journal of medicinal chemistry (2023)
Mu-Chun Li, Mohane Selvaraj Coumar, Shu-Yu Lin, Yih-Shyan Lin, Guan-Lin Huang, Chun-Hwa Chen, Tzu-Wen Lien, Yi-Wen Wu, Yen-Ting Chen, Ching-Ping Chen, Yu-Chen Huang, Kai-Chia Yeh, Chen-Ming Yang, Bikashita Kalita, Shiow-Lin Pan, Tsu-An Hsu, Teng-Kuang Yeh, Chiung-Tong Chen, Hsing-Pang Hsieh
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer. Journal of medicinal chemistry 66 (4) (2023)

Mu-Chun Li.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mu-Chun Li